GlassScriptPhysician profile
Kristina E Lemene
NPI 1780880823
$1,118.98
in general payments reported to CMS, 2019-2025
11 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.25 · 2023: $485 · 2024: $163 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $183.31 | 2025 | Dyanavel Xr |
| Gilead Sciences, INC. | $180.10 | 2023-2025 | Descovy |
| Bayer Healthcare Pharmaceuticals INC. | $156.04 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2024 | Lokelma |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $122.64 | 2023 | |
| Exact Sciences Corporation | $103.98 | 2025 | The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $94.46 | 2023-2024 | Quviviq |
| Sanofi-Aventis U.S. LLC | $88.86 | 2025 | |
| Hologic Sales and Service, LLC | $22.83 | 2025 | Aptima |
| Irhythm Technologies, INC. | $21.14 | 2024 | Zio Xt Patch, Zio Monitor |
| Dexcom, INC. | $20.64 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Lemene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.